01 April 2019 : Clinical Research
Expression and Association of Tumor Necrosis Factor Receptor Associated Factor 4 (TRAF4) in Esophageal Squamous Cell Carcinoma
Peng-Cheng Li1BCDEF, Dan-Dan Hu1BF, Wei Jia1BF, Bing Hu1AG*DOI: 10.12659/MSM.915474
Med Sci Monit 2019; 25:2368-2376
Abstract
BACKGROUND: At present, there is no effective targeted therapy for esophageal squamous cell carcinoma (ESCC), and it is urgent to find new targets for the treatment of ESCC. TRAF4 has been regarded as a cause of carcinogenesis due to overexpression in many cancer types and participation in multiple signaling pathways. However, there are few studies on TRAF4 in ESCC worldwide. Its expression in ESCC and whether it affects the prognosis of patients still remain unclear.
MATERIAL AND METHODS: We detected the expressions of TRAF4, ki-67, and p53 in 100 cases of ESCC and 80 cases of adjacent normal esophageal squamous epithelium tissues by immunohistochemical technique. We further explored the relationship between TRAF4 and ESCC and its prognosis through statistical analysis.
RESULTS: TRAF4 was highly expressed in ESCC tissues and was mainly expressed in the cytoplasm. Overexpression of TRAF4 in ESCC was also associated with high expression of ki-67 and p53 (P<0.05). We also found that patients with high expression of TRAF4 had significantly lower OS than in patients with low TRAF4 expression (P<0.05). Overexpression of TRAF4 was an independent risk factor affecting the prognosis of patients (P<0.05).
CONCLUSIONS: We found that TRAF4 was highly expressed in ESCC tissues and was mainly expressed in the cytoplasm of cancer cells. Overexpression of TRAF4 was an independent risk factor affecting the overall prognosis of patients. The results indicated that TRAF4 may become a new target for the treatment of ESCC in the future.
Keywords: Esophageal Neoplasms, Ki-67 Antigen, Prognosis, TNF Receptor-Associated Factor 4, Tumor Suppressor Protein p53, Aged, Aged, 80 and over, Biomarkers, Tumor, esophageal squamous cell carcinoma, Lymphatic Metastasis, Middle Aged, transcriptome
817 7
Editorial
01 September 2023 : Editorial
Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2DOI: 10.12659/MSM.942244
Med Sci Monit 2023; 29:e942244
In Press
21 Sep 2023 : Clinical Research
The Impact of Implementing the Vortex Approach on Airway Management Performance in Stressed Medical Student...Med Sci Monit In Press; DOI: 10.12659/MSM.940372
20 Sep 2023 : Clinical Research
A Retrospective Study to Compare Pharyngeal Anatomical Changes Measured Before and After Treatment for Malo...Med Sci Monit In Press; DOI: 10.12659/MSM.941749
20 Sep 2023 : Database Analysis
Comparative Finite Element Analysis of Endocrowns and Traditional Restorations for Endodontically Treated M...Med Sci Monit In Press; DOI: 10.12659/MSM.941314
19 Sep 2023 : Laboratory Research
Comparative Evaluation of Dimensional (Vertical/Horizontal) and Occlusal Accuracy of Non-Working Antagonist...Med Sci Monit In Press; DOI: 10.12659/MSM.941654
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952